ShangBay Capital’s William Dai Recognized Among GrowthCap’s Top 25 Healthcare Investors for 2024
Published
PALO ALTO, Calif.--(BUSINESS WIRE)--ShangBay Capital, a prominent venture capital firm specializing in healthcare investments, proudly announces the inclusion of William Dai in GrowthCap's esteemed list of top healthcare investors for 2024. This prestigious accolade celebrates William Dai's exceptional contributions as one of the foremost investors in the healthcare sector, alongside a distinguished cohort of industry leaders. The selection criteria focused on investment expertise, track record
Full Article